Downloads provided by UsageCounts
Immune checkpoint blockade (ICB) therapies are now an important tool in the arsenal for the treatment of advanced cancer extending progression-free survival and overall survival. However, only a subset of cancer patients responds to ICB therapies causing an urgent need for novel approaches to better select patients who may benefit from immunotherapy. Here, we used metastatic ccRCC samples obtained before ICB treatment and performed cell deconvolution analysis to investigate novel biomarkers of ICB treatment response.
[SDV]Life Sciences [q-bio], 610, [INFO.INFO-BI] Computer Science [cs]/Bioinformatics [q-bio.QM]
[SDV]Life Sciences [q-bio], 610, [INFO.INFO-BI] Computer Science [cs]/Bioinformatics [q-bio.QM]
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 12 | |
| downloads | 11 |

Views provided by UsageCounts
Downloads provided by UsageCounts